KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities
Read MoreKBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Characterization Capabilities
JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.
JSR Life Sciences Expands Manufacturing Capabilities at KBI Biopharma
KBI Biopharma and BriaCell Therapeutics Corp. Enter Cell Therapy Manufacturing Agreement for BriaVaxTM Cancer Vaccine
KBI Biopharma Expands Its Services to Include Cell Therapy Manufacturing, Acquires Houston Area Facility
Accelerating timelines vital to securing slice of biosimilars market, KBI
15th August, 2016. Equity investment in initial funding round, license agreement and development project. Dublin, Ireland & Durham, North Carolina,...
Sunnyvale, CA and Tokyo, Japan – February 26, 2015 – JSR Corporation (JSR), along with Tokyo-based CMIC Holdings Co. Ltd. (CMIC) and Innovation...
RESEARCH TRIANGLE PARK, NC– KBI Biopharma, Inc. (KBI) has signed an agreement with Merck & Co., Inc. (known as Merck in the United States and Canada)...
